Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors

EK Nugent, AS Case, JT Hoff, I Zighelboim… - Gynecologic …, 2010 - Elsevier
OBJECTIVES: The aim of this study was to evaluate the effect of number of chemotherapy
cycles and other clinical and pathologic factors on progression-free (PFS) and overall …
被引用次数：81 相关文章

[引用][C] Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors

EK Nugent, AS Case, JT Hoff, I Zighelboim… - Gynecologic …, 2010 - cir.nii.ac.jp
Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and
other clinical prognostic factors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors

EK Nugent, AS Case, JT Hoff… - Gynecologic …, 2010 - pubmed.ncbi.nlm.nih.gov
Objectives The aim of this study was to evaluate the effect of number of chemotherapy cycles
and other clinical and pathologic factors on progression-free (PFS) and overall survival (OS) …

Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.

EK Nugent, AS Case, JT Hoff, I Zighelboim… - Gynecologic …, 2009 - europepmc.org
Objectives The aim of this study was to evaluate the effect of number of chemotherapy cycles
and other clinical and pathologic factors on progression-free (PFS) and overall survival (OS) …

Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors

EK Nugent, AS Case, JT Hoff… - Gynecologic …, 2010 - gynecologiconcology-online.net
Objectives The aim of this study was to evaluate the effect of number of chemotherapy cycles
and other clinical and pathologic factors on progression-free (PFS) and overall survival (OS) …

Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors

EK Nugent, AS Case, JT Hoff, I Zighelboim… - Gynecologic …, 2010 - profiles.wustl.edu
Objectives: The aim of this study was to evaluate the effect of number of chemotherapy
cycles and other clinical and pathologic factors on progression-free (PFS) and overall …

Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors

EK Nugent, AS Case, JT Hoff, I Zighelboim… - Gynecologic …, 2010 - infona.pl
The aim of this study was to evaluate the effect of number of chemotherapy cycles and other
clinical and pathologic factors on progression-free (PFS) and overall survival (OS) in …

[引用][C] Corrigendum to" Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors"[Gynecol. Oncol …

EK Nugent, AS Case, JT Hoff, I Zighelboim… - Gynecologic …, 2010 - profiles.wustl.edu
Corrigendum to "Chemoradiation in locally advanced cervical carcinoma: An analysis of
cisplatin dosing and other clinical prognostic factors" [Gynecol. Oncol. 116 (2010) 438-441] (DOI:10.1016/j.ygyno.2009.09.045) …

[引用][C] Corrigendum to “Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors”[Gynecol. Oncol …

EK Nugent, AS Case, JT Hoff… - Gynecologic …, 2010 - gynecologiconcology-online.net
Corrigendum to “Chemoradiation in locally advanced cervical carcinoma: An analysis of
cisplatin dosing and other clinical prog Page 1 Corrigendum Corrigendum to “Chemoradiation …

[引用][C] Corrigendum to “Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors”[Gynecol. Oncol …

EK Nugent, AS Case, JT Hoff, I Zighelboim… - Gynecologic …, 2010 - infona.pl
Corrigendum to “Chemoradiation in locally advanced cervical carcinoma: An analysis of
cisplatin dosing and other clinical prognostic factors” [Gynecol. Oncol. 116 (2010) 438–441] × …